ストックスクリーナーアプリを入手
0.145
3.65%
-0.0055
前日終値:
$0.1505
開ける：
$0.141
24時間の取引高:
1.82M
Relative Volume:
0.17
時価総額：
$2.92M
収益：
$19.57M
当期純損益:
$-25.12M
株価収益率:
-0.0627
EPS:
-2.3114
ネットキャッシュフロー:
$-19.71M
1週間 パフォーマンス:
-2.62%
1か月 パフォーマンス:
-35.53%
6か月 パフォーマンス:
-86.70%
1年 パフォーマンス:
-95.32%
1日の値動き範囲:
$0.141
$0.1514
1週間の範囲:
$0.1289
$0.1556
52週間の値動き範囲:
$0.1289
$3.42
Vivos Therapeutics Inc Stock (VVOS) Company Profile
名前
Vivos Therapeutics Inc
セクター
電話
(866)908-4867
住所
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
0.145 | 2.83M | 19.57M | -25.12M | -19.71M | -2.3114 |
ABT
Abbott Laboratories
|
98.94 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.48 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.73 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.23 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Vivos Therapeutics Inc (VVOS) 最新ニュース
Vivos Therapeutics Inc (VVOS) Stock Price Target & Forecast - TradingKey
Director at Vivos Therapeutics (VVOS) receives 12,000 stock options - Stock Titan
[Form 4] Vivos Therapeutics, Inc. Insider Trading Activity - Stock Titan
VVOS Form 4 FilingsVivos Therapeutics, Inc. SEC Form 4 - Stock Titan
Vivos Therapeutics Inc. (VVOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Vivos Issues 11.45M Shares to Retire $2.86M of Debt in Dilutive Exchange - Minichart
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Nigeria
Vivos to Issue 11.4M Shares to Settle $2.86M in Debt - minichart.com.sg
Vivos exchanges $2.9m debt for common stock with Streeterville - Investing.com India
Vivos Therapeutics Announces Material Debt Reduction - The Manila Times
Vivos Therapeutics Swaps $2.86M of Streeterville Debt for Up to 11.45M Shares - TradingView
Vivos Therapeutics Inc (NASDAQ: VVOS) Share Price, VVOS Stock News, VVOS Share Price & Updates - Kalkine
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics (VVOS) investor lists 122,963 shares, under 5% - Stock Titan
Regional Sleep & Airway Medicine Center to Be Established in Palm Beach County, Fla - Sleep Review
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - marketscreener.com
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Moomoo
Vivos Therapeutics Inc. (VVOS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - The Manila Times
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com
Vivos Therapeutics partners with Florida cardiology group for sleep center By Investing.com - Investing.com UK
Vivos Therapeutics (VVOS) grants 250K shares, 150K options - Stock Titan
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com Canada
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers - Barchart.com
Vivos Therapeutics Inc (VVOS) Stock News Today - TradingKey
Vivos Therapeutics opens Henderson facility with $10M capacity - Investing.com
Vivos Therapeutics Opens Nevada Sleep Treatment Center - marketscreener.com
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment - The Manila Times
Vivos Therapeutics opens Henderson facility with $10M capacity By Investing.com - Investing.com Canada
Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually - Moomoo
Vivos expects its Nevada sleep center to more than double annual capacity to $10M+ - Stock Titan
Vivos Therapeutics Inc (VVOS) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% on ... By GuruFocus - Investing.com Canada
Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts - Yahoo Finance
Vivos Therapeutics stock falls 6% on second quarter revenue miss By Investing.com - Investing.com Canada
Vivos Therapeutics stock falls 6% on second quarter revenue miss - Investing.com
Conferencia de resultados del 2T de 2026 de Vivos Therapeutics (VVOS): los ingresos suben un 35%, persisten los riesgos de liquidez - TradingKey
Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Umsatz steigt um 35 %, Liquiditätsrisiken bestehen weiterhin - TradingKey
Vivos Therapeutics partners with SPCVA to form AIM Florida - scanx.trade
Vivos Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Vivos Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat
Vivos gets Washington license to manufacture IsoPet - scanx.trade
Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Vivos Therapeutics posts strong Q2 2026 revenue growth - Investing.com Canada
Transcript : Vivos Therapeutics, Inc., Q2 2026 Earnings Call, Aug 14, 2026 - marketscreener.com
Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Vivos Therapeutics reports 35% revenue increase in Q2 2026 By Investing.com - Investing.com Canada
Vivos Therapeutics Q2 revenue up 35%; targets positive cash flow by late 2026 - scanx.trade
Vivos Therapeutics reports 35% revenue increase in Q2 2026 - Investing.com
Vivos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vivos Therapeutics Inc (VVOS) 財務データ
収益
当期純利益
現金流量
EPS
2.41%
0.20%
大文字化:
|
ボリューム (24 時間):